Submitted by Anonymous (not verified) on 5 April 2024 - 16:27
Opinion/decision on a Paediatric investigation plan (PIP): Uptravi, Selexipag, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0088/2023
Source:
